|
US$209.00 · In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
GB 15193.12-2014: National Food Safety Standard -- HGPRT gene mutation test
Status: Valid GB 15193.12: Evolution and historical versions
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status | PDF |
| GB 15193.12-2014 | English | 209 |
Add to Cart
|
3 days [Need to translate]
|
National Food Safety Standard -- HGPRT gene mutation test
| Valid |
GB 15193.12-2014
|
| GB 15193.12-2003 | English | 199 |
Add to Cart
|
2 days [Need to translate]
|
V79/HGPRT gene mutation test
| Obsolete |
GB 15193.12-2003
|
| GB 15193.12-1994 | English | 199 |
Add to Cart
|
2 days [Need to translate]
|
V79/HGPRT gene mutation test
| Obsolete |
GB 15193.12-1994
|
PDF similar to GB 15193.12-2014
Basic data | Standard ID | GB 15193.12-2014 (GB15193.12-2014) | | Description (Translated English) | National Food Safety Standard -- HGPRT gene mutation test | | Sector / Industry | National Standard | | Classification of Chinese Standard | C53 | | Classification of International Standard | 07.100 | | Word Count Estimation | 9,932 | | Date of Issue | 12/24/2014 | | Date of Implementation | 5/1/2015 | | Older Standard (superseded by this standard) | GB 15193.12-2003 | | Regulation (derived from) | Health Planning Commission Bulletin 2014 No. 21 | | Issuing agency(ies) | National Health and Family Planning Commission of the People's Republic of China | | Summary | This Standard specifies in vitro mammalian cell hypoxanthine guanine phosphoribosyl transferase (HGPRT) gene mutation test basic test methods and technical requirements. This Standard is applicable to the evaluation of mutagenicity test substance. | GB 15193.12-2014: National Food Safety Standard -- HGPRT gene mutation test---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
National Food Safety Standard.HGPRT gene mutation test
National Standards of People's Republic of China
National Food Safety Standard
In vitro mammalian cell gene mutation test HGPRT
Issued on.2014-12-24
2015-05-01 implementation
People's Republic of China
National Health and Family Planning Commission released
Foreword
This standard replaces GB 15193.12-2003 "in vitro mammalian cell (V79/HGPRT) gene mutation assay."
This standard compared with GB 15193.12-2003, the main changes are as follows.
--- Standard name was changed to "national food safety standard in vitro mammalian cell gene mutation test HGPRT";
--- Increasing the terms and definitions;
--- Modified test purposes and principles;
--- Increasing the method of preparation of different types of test substance;
--- Increasing the reference positive control;
--- Increased test cell lines.
National Food Safety Standard
In vitro mammalian cell gene mutation test HGPRT
1 Scope
This standard specifies the in vitro mammalian cell hypoxanthine guanine phosphoribosyl transferase (HGPRT) gene mutation test basic test
Test methods and technical requirements.
This standard applies to the evaluation of the test substance mutagenic effect.
2 Terms and definitions
2.1 HGPRT gene
Hypoxanthine guanine phosphoribosyl transferase gene in mammals. In humans, HGPRT gene located on the X chromosome length
Arm coordinates Xq26.1; in mice also located in the X chromosome.
2.2 mutation frequency
In some cell lines, a particular gene mutant cells (colonies) accounted cells (colonies) of the total percentage.
3 test purposes and principles
Cells under normal culture conditions, capable of HGPRT-generating, selectively containing 6-thioguanine (6-thioguanine, 6-TG) of
Culture medium, HGPRT catalyzes the production of nucleoside-5'-monophosphate (NMP), NMP incorporated into the DNA resulting in cell death. Carcinogenic and (or)
Mutagen effect, the control structure of HGPRT gene mutation on the X chromosome in some cells can no longer produce HGPRT, thereby
So that the mutant cells to 6-TG resistant effect, can survive in a selective growth medium containing 6-TG in.
In addition and without the addition of metabolic activation system conditions, the cells were exposed to test a certain time, then the cells were subcultured,
Selective medium containing 6-TG, the mutant cells can continue to divide and form colonies. Based on the number of mutant colonies calculated mutation frequency
To evaluate the mutagenicity of the test substance.
4 Materials and Reagents
4.1 Cell
Common Chinese hamster lung cell line (V79) and Chinese hamster ovary cell line (CHO), others such as mouse lymphoma cells (L5178Y)
And human lymphoblastoid cell lines (TK6) also. Cells should be carried out before use to check whether the mycoplasma contamination.
4.2 broth
According to the test system should be used to select the appropriate cell type and medium. For V79 and CHO cells, common minimum essential medium
Yang group (MEM, Eagle), Modified Eagle Medium (DMEM) with 10% fetal calf serum and an appropriate amount of antibiotics. For TK6 and
L5178Y cells, commonly used RPMI1640 medium, 10% horse serum (culture flasks) or 20% horse serum (96 well plates) and
An appropriate amount of antibiotics (penicillin, streptomycin).
4.3 trypsin/EDTA solution
With calcium and magnesium in PBS, concentration of trypsin was 0.05%, the concentration of EDTA is 0.02% trypsin EDTA solution by
Mixed 1. -20 ℃ storage.
4.4 activation system
S9 mixture is generally used. S9 is prepared as follows.
Choose healthy male adult SD or Wistar rats weighing about 150g ~ 200g, weeks about five weeks to 6 weeks. The PCBs
(Aroclor1254) was dissolved in corn oil at a concentration of 200g/L, according to 500mg/kg body weight by intraperitoneal injection once aseptic, 5d after death
Animals were sacrificed before fasting 12h.
It may also be used phenobarbital and β- naphthalene flavones and induction methods for preparing orally administered to rats fed sodium phenobarbital and β- naphthalene
Flavonoids, doses were 80mg/kg, continuous 3d, 16h after fasting animals were decapitated. Other operating with PCBs induction.
Animals were sacrificed after the liver was removed, weighed fresh ice-cold solution of potassium chloride (0.15mol/L) continuous flushing liver several times to remove
It can inhibit the activity of microsomal hemoglobin. Per gram of liver (wet weight) was added potassium chloride solution (0.1mol/L) 3mL, along with an ice bath and transferred to a beaker
The liver minced with sterile scissors in glass homogenizer (less than 4000r/min, 1min ~ 2min) or tissue homogenizer (less than
20000r/min, 1min) is made in the liver homogenates. The above operation should pay attention to the local cold and sterile environment.
The liver homogenates prepared at low temperature (0 ℃ ~ 4 ℃) high-speed centrifuge at 9000g centrifugation 10min, the supernatant was aspirated S9 fraction,
Aliquot in sterile freezer tubes or ampoules, each ampoule about 2mL, frozen with liquid nitrogen or dry ice rear -80 ℃ cryopreservation.
After S9 fraction prepared by the sterility test, measuring protein content (Lowry method) per milliliter protein content of not more than 40mg is appropriate, and by
Indirect carcinogens (mutagens) Qualified identify their biological activity after storage in cryogenic freeze or dry, a period not exceeding one year.
S9 is used at a concentration of 1% to 10% (final concentration).
4.5 selection agent
6- thioguanine (6-TG), recommend using a final concentration of 5μg/mL ~ 15μg/mL, formulated with sodium bicarbonate solution (0.5%).
4.6 pretreated broth (THMG/T HG)
To reduce the frequency of spontaneous mutation of cells, prior to testing, the first cell culture plus 24h in culture medium containing THMG, the spontaneous killing
The mutant cells, then cells were seeded in THG (without methotrexate in THMG broth) in cultured cells 1d ~ 3d to recovery
Normal growth cycle and morphology.
THMG final concentration of each substance contained in the following (in addition to the culture medium ingredients outside).
--- Thymidine, 5 × 10-6mol/L;
--- Hypoxanthine, 5 × 10-5mol/L;
--- Methotrexate, 4 × 10-7mol/L;
--- Glycine, 1 × 10-4mol/L.
5 Test methods
5.1 test substance
5.1.1 formulated test substance
Solid test substances should be dissolved or suspended in a suitable solvent and diluted to the appropriate concentration. Liquid test substances can be used directly or diluted to
Appropriate concentration. Test substance shall be obtained before using now, otherwise you must confirm the storage does not affect its stability.
5.1.2 vehicle selection
Solvent must be non-mutagenic not react chemically with the test substance, does not affect cell survival and S9 activity. The preferred solvent is distilled
Water; for water-insoluble test substance optionally other solvents, preferred dimethyl sulfoxide (DMSO), but it should not be used at a concentration greater than 0.5%.
5.1.3 Control
Each one trial, in the presence of metabolic activation system and the absence shall be provided with positive and negative (vehicle) control group.
5.1.3.1 Positive Control
When using a metabolic activation system, the positive control is to require metabolic activation must be, and can cause mutations in substance, you can use 3-methyl
MCA (3-methylcholanthrene), N- NDMA (N-nitroso-dimethylamine), 7,12- dimethyl-benz [a] anthracene (7,
12-dimethylbenz [a] anthracene) and the like. In the absence of metabolic activation system, the positive control can be used ethyl methane sulfonate (ethyl
methanesulphonate), ethylnitrosourea (ethylnitrosourea) and the like. It may also be used other suitable positive controls.
5.1.3.2 the negative control
Negative control (including vehicle control) in addition to absence of the test substance, the other test substances should be treated the same. In addition, not having a laboratory history
When data confirm vehicle used no mutagenic effect and no other harmful effects, but also blank control.
5.2 dose
5.2.1 Select the highest concentration
The factors that determine the cytotoxic highest concentration, pH or osmotic pressure and changing the solubility test substance in the assay system.
5.2.2 determine cytotoxicity
Integrity should be used and an indication of cell growth indicators, to determine the cytotoxicity of metabolic activation system in the presence and absence of two conditions
, For example colony formation relative or relative survival rate. It shall determine cytotoxicity and solubility in the pre-test.
5.2.3 density settings and select the highest concentration
It should be set at least four concentrations available for analysis. When cytotoxic concentration should include toxicity from the largest to the almost non-toxic,
Typically the concentration factor in the interval between 2 to 10; as the highest concentration is based on cytotoxicity then the cell concentrations relative colony forming efficiency
Or the relative survival rates of 10% to be 20% (not less than 10%). For those low cytotoxic compounds the maximum concentration should be
5μL/mL, 5mg/mL or 0.01mol/L. For relatively insoluble substances, the highest concentration should meet or exceed the dendritic cells in culture
The solubility limit of the state; the best and the end of the trial process begins in solubility were evaluated, such as the presence of S9, the internal system test
Exposure during the solubility may vary; insolubility can be visually identified, but should not affect the precipitation was observed.
5.3 Test procedure and outcome measures
5.3.1 adherent cell growth test procedures and outcome measures
5.3.1.1 Cell preparation
The 5 × 105 cells were seeded in 100mm diameter dish at 37 ℃, 5% carbon dioxide incubator for 24h.
5.3.1.2 contact with the test substance
Culture fluid was aspirated, PBS washed twice, adding a certain amount of serum-free medium, a certain concentration of the test substance and S9 mixture (without metabolic
Activated by serum-free culture medium supplement), placed in an incubator in 3h ~ 6h, after the aspirated medium containing the test substance, the cells were washed with PBS
Twice, change into the culture medium containing 10% serum, cultured 19h ~ 22h.
5.3.1.3 Expression
Contacting the test cells were cultured for 19h ~ 22h after digestion with trypsin -EDTA, until the cells fall off, containing 10% serum
Medium to terminate digestion, and mix into a centrifuge tube to 800r/min ~ 1000r/min speed centrifugal 5min ~ 7min, the supernatant was discarded,
Cell suspension, counted to 5 × 105 cells were seeded in 100mm diameter plates, 3d passaged, inoculated with 5 × 105 Ge still fine
Cell culture 3d (optimal expression time 6d ~ 8d).
5.3.1.4 cytotoxicity assay
The first count after digestion of said cells per dish inoculated with 200, five each dish, at 37 ℃, 5% carbon dioxide cultured 7d,
Fixed, Giemsa staining, counting the number of colonies per dish.
Select and set the rate of colony formation assay 5.3.1.5 mutants
After expression, digestive cells, minutes, each group of five dishes, each dish inoculated with 200 cells, without 6-TG, 7d after fixed, Giemsa staining
Color, the number of colonies per dish statistical calculation colony formation rate. Another mutation frequency was measured while doing, each set of five dishes, each dish was inoculated 2 × 105 cells,
To be adherent cells were added to 6-TG (recommended final concentration of 5μg/mL ~ 10μg/mL), placed in incubator 8d ~ 10d after the solid
Fixed, Giemsa staining, statistical colonies per dish, and calculate the frequency of mutation.
Procedures and observed indicators 5.3.2 Suspension cell growth
5.3.2.1 Preparation of cells and contacting the test substance
Take good cell growth, adjusting a density of 5 × 105/mL, 1% by volume of a series of concentrations of the test substance and S9 mix (without
Metabolic activation by serum-free culture medium supplement), 37 ℃ shaking process 3h ~ 6h, to 800r/min ~ 1000r/min speed centrifugation
4min ~ 6min, the supernatant with PBS or serum-free medium cells were washed twice, resuspended in 10% horse serum RPMI cells
1640, and adjust the cell density of 2 × 105/mL.
5.3.2.2 PE0 (0 days plated efficiency) Determination
Take appropriate cell suspension for dilution to 108 cells/mL, inoculated 96 (per well 0.2mL, an average of 1.6 cells /
Well), inoculated with each dose of 1 to 2 plates, at 37 ℃, 5% carbon dioxide and saturated humidity cultured 9d ~ 11d, counting each plate has
Growth of colonies set number of holes.
5.3.2.3 Expression
5.3.2.1 The resulting cell suspension was taken, as 6d expression culture, the cell density counted daily and maintained at a density 1 × 106/mL or less.
5.3.2.4 PE6 (the sixth day of plating efficiency) Determination
After the end of the expression of the culture, take appropriate cell suspension, according to "5.3.2.2" method of measuring PE6.
5.3.2.5 mutation frequency (MF) Determination
After the expression of culture, take the appropriate cell suspension, adjusting the cell density of 1 × 105/mL, was added 6-TG (recommended final concentration of
5μg/mL ~ 15μg/mL), mixed, seeded 96 well plates (0.2mL added per well, i.e., 2 × 104 cells/well), inoculated with 2 ~ each dose
4 plates, at 37 ℃, 5% carbon dioxide and saturated humidity cultured 11d ~ 14d, count mutation colonies growing number of holes.
6 Data processing and evaluation of results
6.1 Data Processing
6.1.1 The growth of adherent cells HGPRT Test Data Processing
6.1.1.1 Cytotoxicity
With respect to the vehicle control group set off the formation rate indicates cytotoxicity. Namely vehicle control colonies was 100% (1.00) is formed, seeking
The relative value of each test substance group.
Relative colony forming efficiency calculation see formula (1).
A = B/C × 100% (1)
Where.
A --- relative colony forming rate,%;
B --- test substance group colony formation rate,%;
Vehicle control group C --- colony formation rate,%.
6.1.1.2 colony formation and mutation frequency
Colony formation rate calculation see formula (2).
D = E/F × 100% (2)
Where.
D --- colony formation rate,%;
E --- actual viable cell colonies;
F --- inoculated cells.
See the mutation frequency calculation formula (3).
G =
I ×
(3)
Where.
G --- mutation frequency;
H --- mutant colonies;
I --- inoculated cells;
D --- colony formation rate.
6.1.2 suspension grown cells HGPRT Test Data Processing
6.1.2.1 plating efficiency (PE0, PE6)
Plating efficiency calculation see formula (4).
PE = -
ln (EW/TW)
1.6 × 100%
(4)
Where.
EW --- no colony growth of the number of holes;
TW --- Total number of holes;
1.6 --- inoculated cells per well.
6.1.2.2 Relative survival (RS)
Relative survival calculation see formula (5).
RS =
PE0 (test substance group)
PE0 (vehicle control group) ×
100% (5)
6.1.2.3 mutation frequency (MF)
Mutation frequency calculation see formula (6).
MF (× 10-6) = -
ln (EW/TW)/N
PE6
(6)
Where.
EW --- no colony growth of the number of holes;
TW --- Total number of holes;
N --- per seeded cell number that is 2 × 104;
PE6 --- sixth day of plating efficiency.
6.2 Evaluation Results
6.2.1 determination positive results
6.2.1.1 mutation frequency test substance group in any one or more doses of negative (vehicle) control group three times or three times, can be determined
Positive.
6.2.1.2 mutation frequency test group was increased, and negative (vehicle) control group was statistically significant and dose - response trend, the
It may be assessed as positive.
6.2.1.3 the test was set to cause a statistically significant increase in any condition and has a dose reproducibility can be judged as positive.
6.2.2 determination negative results
Positive results do not meet these criteria, it is judged as negative.
7 Test report
7.1 Name of test, the test unit name and contact details, report number.
7.2 Test Requester name and contact information, sample acceptance date.
7.3 Test start and end dates, test project manager, technical director of the test unit, date of issue.
7.4 test summary.
7.5 test substance. name, identification data, CAS number (if known), purity, and with the physical and chemical properties of the test related to the test substance
Stability.
7.6 vehicle and vehicle. vehicle and carrier selection basis, solubility and stability of the test substance in a solvent and carrier.
7.7 cell lines. name, source, concentration and culture conditions (including the composition of the medium, temperature, CO2 concentration and incubation time).
7.8 Test conditions. dosage, metabolic activation system, mutagens, and other steps.
7.9 Test Results. The test substance dosage groups (with and without S9) cytotoxicity and mutation frequency of the mean and standard deviation, whether the agent
Volume - response relationship, the statistical results, simultaneous negative (solvent) and positive controls the mean and standard deviation, and negative (vehicle) control
And positive controls historic range.
7.10 Conclusion. Under the experimental conditions of the test was whether the mutagenic effect.
Explanation 8 trial
If the negative control, the colony formation or survival rate below 50%, the result should not be used. Each laboratory selected positive control mutation frequency
Rate range, if the result of the test was negative or weakly positive, positive control mutation rate should reach above the lower limit of normal, otherwise the knot
Fruit can not be established.
Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of GB 15193.12-2014_English be delivered?Answer: Upon your order, we will start to translate GB 15193.12-2014_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time. Question 2: Can I share the purchased PDF of GB 15193.12-2014_English with my colleagues?Answer: Yes. The purchased PDF of GB 15193.12-2014_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet. Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay. Question 5: Should I purchase the latest version GB 15193.12-2014?Answer: Yes. Unless special scenarios such as technical constraints or academic study, you should always prioritize to purchase the latest version GB 15193.12-2014 even if the enforcement date is in future. Complying with the latest version means that, by default, it also complies with all the earlier versions, technically.
|